174 related articles for article (PubMed ID: 14607443)
1. Proton magnetic resonance spectroscopy can detect creatine depletion associated with the progression of heart failure in cardiomyopathy.
Nakae I; Mitsunami K; Omura T; Yabe T; Tsutamoto T; Matsuo S; Takahashi M; Morikawa S; Inubushi T; Nakamura Y; Kinoshita M; Horie M
J Am Coll Cardiol; 2003 Nov; 42(9):1587-93. PubMed ID: 14607443
[TBL] [Abstract][Full Text] [Related]
2. Clinical features of myocardial triglyceride in different types of cardiomyopathy assessed by proton magnetic resonance spectroscopy: comparison with myocardial creatine.
Nakae I; Mitsunami K; Yoshino T; Omura T; Tsutamoto T; Matsumoto T; Morikawa S; Inubushi T; Horie M
J Card Fail; 2010 Oct; 16(10):812-22. PubMed ID: 20932463
[TBL] [Abstract][Full Text] [Related]
3. Assessment of myocardial creatine concentration in dysfunctional human heart by proton magnetic resonance spectroscopy.
Nakae I; Mitsunami K; Matsuo S; Matsumoto T; Morikawa S; Inubushi T; Koh T; Horie M
Magn Reson Med Sci; 2004 Apr; 3(1):19-25. PubMed ID: 16093616
[TBL] [Abstract][Full Text] [Related]
4. Creatine depletion and altered fatty acid metabolism in diseased human hearts: clinical investigation using 1H magnetic resonance spectroscopy and 123I BMIPP myocardial scintigraphy.
Nakae I; Mitsunami K; Matsuo S; Horie M
Acta Radiol; 2007 May; 48(4):436-43. PubMed ID: 17453526
[TBL] [Abstract][Full Text] [Related]
5. Energetics and function of the failing human heart with dilated or hypertrophic cardiomyopathy.
Kalsi KK; Smolenski RT; Pritchard RD; Khaghani A; Seymour AM; Yacoub MH
Eur J Clin Invest; 1999 Jun; 29(6):469-77. PubMed ID: 10354207
[TBL] [Abstract][Full Text] [Related]
6. Myocardial creatine concentration in various nonischemic heart diseases assessed by 1H magnetic resonance spectroscopy.
Nakae I; Mitsunami K; Matsuo S; Inubushi T; Morikawa S; Tsutamoto T; Koh T; Horie M
Circ J; 2005 Jun; 69(6):711-6. PubMed ID: 15914951
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of 1H MR spectroscopy in the evaluation of myocardial metabolism in patients with dilated idiopathic cardiomyopathy: pilot study.
Walecki J; Michalak MJ; Michalak E; Bilinska ZT; Ruzyllo W
Acad Radiol; 2003 Oct; 10(10):1187-92. PubMed ID: 14587640
[TBL] [Abstract][Full Text] [Related]
8. Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with (31)P-SLOOP magnetic resonance spectroscopy.
Beer M; Seyfarth T; Sandstede J; Landschütz W; Lipke C; Köstler H; von Kienlin M; Harre K; Hahn D; Neubauer S
J Am Coll Cardiol; 2002 Oct; 40(7):1267-74. PubMed ID: 12383574
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of delayed enhancement magnetic resonance imaging to differentiate dilated phase of hypertrophic cardiomyopathy and dilated cardiomyopathy.
Matoh F; Satoh H; Shiraki K; Saitoh T; Urushida T; Katoh H; Takehara Y; Sakahara H; Hayashi H
J Card Fail; 2007 Jun; 13(5):372-9. PubMed ID: 17602984
[TBL] [Abstract][Full Text] [Related]
10. The relationship between plasma BNP level and the myocardial phosphocreatine/adenosine triphosphate ratio determined by phosphorus-31 magnetic resonance spectroscopy in patients with dilated cardiomyopathy.
Chida K; Otani H; Kohzuki M; Saito H; Kagaya Y; Takai Y; Takahashi S; Yamada S; Zuguchi M
Cardiology; 2006; 106(3):132-6. PubMed ID: 16636542
[TBL] [Abstract][Full Text] [Related]
11. Is cardiac and hepatic iron status assessed by MRI T2* associated with left ventricular function in patients with idiopathic cardiomyopathy?
Kanzaki Y; Yuki M; Yamamura KI; Narumi Y; Ishizaka N
Heart Vessels; 2016 Dec; 31(12):1950-1959. PubMed ID: 26897743
[TBL] [Abstract][Full Text] [Related]
12. Cardiac metabolism in patients with dilated and hypertrophic cardiomyopathy: assessment with proton-decoupled P-31 MR spectroscopy.
de Roos A; Doornbos J; Luyten PR; Oosterwaal LJ; van der Wall EE; den Hollander JA
J Magn Reson Imaging; 1992; 2(6):711-9. PubMed ID: 1446116
[TBL] [Abstract][Full Text] [Related]
13. Regional heterogeneity of decreased myocardial norepinephrine and increased lipid peroxidation levels in patients with end-stage failing heart secondary to dilated or ischemic cardiomyopathy.
Rochette L; Tatou E; Vergely C; Maupoil V; Bouchot O; Mossiat C; Jazayeri S; Benkhadra S; Brenot R; Girard C; David M
J Heart Lung Transplant; 2008 Jul; 27(7):767-74. PubMed ID: 18582807
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of nonscarred myocardial T1 value using contrast-enhanced look-locker cardiac MRI and its relationship to cardiac function in dilated cardiomyopathy: Comparison of 1.5 and 3.0 Tesla MRI.
Tachi M; Amano Y; Kobayashi Y; Mizuno K; Kumita S
J Magn Reson Imaging; 2013 Dec; 38(6):1395-401. PubMed ID: 23852918
[TBL] [Abstract][Full Text] [Related]
15. Myocardial triglyceride content in patients with left ventricular hypertrophy: comparison between hypertensive heart disease and hypertrophic cardiomyopathy.
Sai E; Shimada K; Yokoyama T; Hiki M; Sato S; Hamasaki N; Maruyama M; Morimoto R; Miyazaki T; Fujimoto S; Tamura Y; Aoki S; Watada H; Kawamori R; Daida H
Heart Vessels; 2017 Feb; 32(2):166-174. PubMed ID: 27142065
[TBL] [Abstract][Full Text] [Related]
16. [Myocardial lipids and creatine measured by magnetic resonance spectroscopy among patients with heart failure].
Winter JL; Castro P; Meneses L; Chalhub M; Verdejo H; Greig D; Gabrielli L; Chiong M; Concepción R; Mellado R; Hernández C; Uribe S; Lavandero S
Rev Med Chil; 2010 Dec; 138(12):1475-9. PubMed ID: 21526294
[TBL] [Abstract][Full Text] [Related]
17. Myocardial production of chromogranin A in human heart: a new regulatory peptide of cardiac function.
Pieroni M; Corti A; Tota B; Curnis F; Angelone T; Colombo B; Cerra MC; Bellocci F; Crea F; Maseri A
Eur Heart J; 2007 May; 28(9):1117-27. PubMed ID: 17389654
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil Extracellular Traps in Myocardial Tissue Drive Cardiac Dysfunction and Adverse Outcomes in Patients With Heart Failure With Dilated Cardiomyopathy.
Ichimura S; Misaka T; Ogawara R; Tomita Y; Anzai F; Sato Y; Miura S; Yokokawa T; Sato T; Oikawa M; Kobayashi A; Yoshihisa A; Takeishi Y
Circ Heart Fail; 2024 Jun; 17(6):e011057. PubMed ID: 38847093
[TBL] [Abstract][Full Text] [Related]
19. Inducible nitric oxide synthase and tumor necrosis factor-alpha in myocardium in human dilated cardiomyopathy.
Satoh M; Nakamura M; Tamura G; Makita S; Segawa I; Tashiro A; Satodate R; Hiramori K
J Am Coll Cardiol; 1997 Mar; 29(4):716-24. PubMed ID: 9091515
[TBL] [Abstract][Full Text] [Related]
20. Plasma osteopontin levels in patients with dilated and hypertrophic cardiomyopathy.
Podzimkova J; Palecek T; Kuchynka P; Marek J; Danek BA; Jachymova M; Kalousova M; Zima T; Linhart A
Herz; 2019 Jun; 44(4):347-353. PubMed ID: 29147972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
